🇺🇸 FDA
Patent

US 11034956

Oligonucleotide comprising an inosine for treating DMD

granted A61KA61K48/00A61P

Quick answer

US patent 11034956 (Oligonucleotide comprising an inosine for treating DMD) held by BIOMARIN TECHNOLOGIES B.V. expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN TECHNOLOGIES B.V.
Grant date
Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K48/00, A61P, A61P21/00, A61P29/00